User menu

Effects of long-term xamoterol therapy on the left ventricular mechanical efficiency in patients with ischemic heart disease.

Bibliographic reference Pouleur, H. ; van Eyll, Christian ; Etienne, J. ; Van Mechelen, Henri ; Vuylsteke, A. ; et. al. Effects of long-term xamoterol therapy on the left ventricular mechanical efficiency in patients with ischemic heart disease.. In: Basic research in cardiology, Vol. 84 Suppl 1, p. 157-62 (1989)
Permanent URL http://hdl.handle.net/2078.1/13936
  1. Braunwald E (1971) Control of myocardial oxygen consumption. Am J Cardiol 27:416–432
  2. Davidson S, Maroko PR, Braunwald E (1974) Effects of isoproterenol on contractile function of the ischemic and anoxic heart. Am J Physiol 227:439–443
  3. Ford L. E., Effect of afterload reduction on myocardial energetics, 10.1161/01.res.46.2.161
  4. Gertz E. W., Wisneski J. A., Neese R., Bristow J. D., Searle G. L., Hanlon J. T., Myocardial lactate metabolism: evidence of lactate release during net chemical extraction in man, 10.1161/01.cir.63.6.1273
  5. Graham Thomas P., Covell James W., Sonnenblick Edmund H., Ross John, Braunwald Eugene, Control of myocardial oxygen consumption: relative influence of contractile state and tension development, 10.1172/jci105734
  6. Gunning JF, Coleman HN (1973) Myocardial oxygen consumption during experimental hypertrophy and congestive heart failure. J Molec Cell Cardiol 5:25–38
  7. Hasenfuss G, Holubarsch C, Heiss HW, Bonzel T, Meinertz T, Just H (1986) Influence of enoximone and isoproterenol on myocardial energetics in the human heart, Abstract. Circulation 74(II):II-398
  8. Nichols AB, Pearson MH, Sciacca RR, Cannon PJ (1986) Left ventricular mechanical efficiency in coronary artery disease. J Am Coll Cardiol 7:270–279
  9. NUTTALL A., SNOW H.M., THE CARDIOVASCULAR EFFECTS OF ICI 118,587: A β1-ADRENOCEPTOR PARTIAL AGONIST, 10.1111/j.1476-5381.1982.tb09309.x
  10. Pouleur H, Marechal G, Balasim H, Van Mechelen H, Ries A, Rousseau MF, Charlier AA (1983) Effects of dobutamine and sulmazol (AR-L115 BS) on myocardial metabolism, coronary, femoral and renal blood flows: a comparative study in normal dogs and in dogs with chronic volume overload. J Cardiovasc Pharmacol 5:861–867
  11. Pouleur H, Rousseau MF, Hanet C, Marlow HF, Charlier AA (1987) Left ventricular sensitivity toβ-adrenoceptor stimulating drugs in patients with ischemic heart disease and varying degrees of ventricular dysfunction. Circ Res 61(I):I91-I95
  12. Pouleur H., Rousseau M. F., van Eyll C., Charlier A. A., Assessment of regional left ventricular relaxation in patients with coronary artery disease: importance of geometric factors and changes in wall thickness, 10.1161/01.cir.69.4.696
  13. Pouleur H, Rousseau MF, van Eyll C, Gurné O, Hanet C, Charlier AA (1986) Impaired regional diastolic distensibility in coronary artery disease, relations with dynamic left ventricular compliance. Am Heart J 112:721–728
  14. Pouleur H, van Eyll C, Cheron P, Hanet C, Charlier AA, Rousseua MF (1986) Changes in left ventricular filling dynamics after long-term xamoterol therapy in ischemic left ventricular dysfunction. Heart Failure 2:176–184
  15. Pouleur H., van Eyll C., Hanet C., Cheron P., Charlier A. A., Rousseau M. F., Long-term effects of xamoterol on left ventricular diastolic function and late remodeling: a study in patients with anterior myocardial infarction and single-vessel disease, 10.1161/01.cir.77.5.1081
  16. Pouleur H, Van Mechelen H, Balasim Habib, Rousseau MF, Charlier AA (1984) Comparisons of the inotropic effects of theβ 1-adrenoceptor partial agonists SL 75.177.10 and ICI 188,587 with digoxin on the intact canine heart. J Cardiovasc Pharmacol 6:720–726
  17. Pozen R. G., DiBianco R., Katz R. J., Bortz R., Myerburg R. J., Fletcher R. D., Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease, 10.1161/01.cir.63.6.1279
  18. Rousseau MF, Cheron P, Nannan M, Vincent MF, Lavenne F, Pouleur H (1985) Place des agonistes partiels des récepteursβ-adrénergiques dans l’insuffisance ventriculaire gauche d’origine ischémique. Intérêt du Xamotérol (ICI 118,587, Corwin). Ann Med Int 136:247–250
  19. Rousseau MF, Pouleur H, Vincent MF (1983) Effects of a cardioselective beta-1-partial agonist (Corwin) on left ventricular function and myocardial metabolism in patients with previous myocardial infarction. Am J Cardiol 51:1267–1274
  20. Rousseau M. F., Veriter C., Detry J. M., Brasseur L., Pouleur H., Impaired early left ventricular relaxation in coronary artery disease: effects of intracornary nifedipine, 10.1161/01.cir.62.4.764
  21. van Eyll C, Rousseau MF, Pouleur H, Charlier AA, Brasseur LA (1982) Algorithms for wall motion analysis: importance of data smoothing and correct determination of end-systole. In Computers in Cardiology Seattle, IEEE Computer Society, pp 413–416
  22. Weber KT, Janicki JS (1979) The metabolic demand and oxygen supply of the heart: physiologic and clinical considerations. Am J Cardiol 44:722–729